We aim to review Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) cases at our institution, to complement existing published data for future changes to disease guidelines.
No takes yet. Share an insight, caveat, or question.
Bernfeld et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: